CorriX™
A Science-Based Product

Unstoppable in generating scientific evidences

LEARN ABOUT CorriX™

CorriX™
A Science-Based Product

CorriX™ helps empowering the immune system to support the development of natural and specific Thomsen-Friedenreich-antibodies, TFα-antibodies, which are important for the body’s natural immune health. In by now 10 years from lab to market, we succeeded to isolate the proprietary CorriX™-strain Bacteroides xylanisolvens and to develop it for use in dietary supplements and functional food. Since the beginning of this project we set a strong focus on scientific evidences which have been all published in peer-reviewed journals:

Human efficacy study

A randomized, double-blind, placebo controlled trial demonstrated that CorriX™ induces the development of natural TFα-antibodies in humans

Ulsemer et al., Benef Microbes, 2016 Apr 6:1-16

Animal efficacy study

TFα-antigen-expressing Bacteroides induces the development of natural TFα-antibodies in mice.

Ulsemer et al., Cancer Immunol Immunother, 2013 May;62(5):875-87

 

Safety

The CorriX™-strain Bacteroides xylanisolvens is safe for human consumption

Ulsemer et al., 2012, Appl Environ Microbiol

Ulsemer et al., 2012, Regul Toxicol Pharmacol

Ulsemer et al., 2012, Benef Microbes

Discovery

The CorriX™-strain Bacteroides xylanisolvens was isolated from a healthy human gut and is a new Bacteroides xylanisolvens strain.

Ulsemer et al., 2012, Appl Environ Microbiol

Contact us

Contact us